Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

Chest. 2001 Jan;119(1 Suppl):64S-94S. doi: 10.1378/chest.119.1_suppl.64s.
No abstract available

Publication types

  • Review

MeSH terms

  • Angina, Unstable / drug therapy
  • Anticoagulants* / adverse effects
  • Anticoagulants* / pharmacokinetics
  • Anticoagulants* / pharmacology
  • Anticoagulants* / therapeutic use
  • Coronary Disease / drug therapy
  • Heparin* / adverse effects
  • Heparin* / pharmacokinetics
  • Heparin* / pharmacology
  • Heparin* / therapeutic use
  • Heparin, Low-Molecular-Weight* / adverse effects
  • Heparin, Low-Molecular-Weight* / pharmacokinetics
  • Heparin, Low-Molecular-Weight* / pharmacology
  • Heparin, Low-Molecular-Weight* / therapeutic use
  • Humans
  • Myocardial Infarction / drug therapy
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Heparin